...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4(+) T Lymphocytes.
【24h】

Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4(+) T Lymphocytes.

机译:细胞外腺嘌呤核苷酸抑制人类CD4(+)T淋巴细胞的激活。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ATP has been reported to inhibit or stimulate lymphoid cell proliferation, depending on the origin of the cells. Agents that increase cAMP, such as PGE(2), inhibit human CD4(+) T cell activation. We demonstrate that several ATP derivatives increase cAMP in both freshly purified and activated human peripheral blood CD4(+) T cells. The rank order of potency of the various nucleotides was: adenosine 5'-O-(3-thiotriphosphate) (ATPgammaS) approximately 2'- and 3'-O-(4-benzoylbenzoyl) ATP (BzATP) > ATP > 2-methylthio-ATP dATP, 2-propylthio-beta,gamma-dichloromethylene-D-ATP, UDP, UTP. This effect did not involve the activation of A(2)Rs by adenosine or the synthesis of prostaglandins. ATPgammaS had no effect on cytosolic calcium, whereas BzATP induced an influx of extracellular calcium. ATPgammaS and BzATP inhibited secretion of IL-2, IL-5, IL-10, and IFN-gamma; expression of CD25; and proliferation after activation of CD4(+) T cells by immobilized anti-CD3 and soluble anti-CD28 Abs, without increasing cell death. Taken together, our results suggest that extracellular adenine nucleotides inhibit CD4(+) T cell activation via an increase in cAMP mediated by an unidentified P2YR, which might thus constitute a new therapeutic target in immunosuppressive treatments.
机译:据报道,取决于细胞的来源,ATP可抑制或刺激淋巴样细胞增殖。增加cAMP的试剂,例如PGE(2),抑制人CD4(+)T细胞活化。我们证明了几个ATP衍生物增加新鲜纯化和激活的人类外周血CD4(+)T细胞中的cAMP。各种核苷酸的效价等级顺序为:腺苷5'-O-(3-硫代三磷酸)(ATPgammaS)约2'-和3'-O-(4-苯甲酰基苯甲酰基)ATP(BzATP)> ATP> 2-甲硫基-ATP dATP,2-丙硫基-β,γ-二氯亚甲基-D-ATP,UDP,UTP。此作用不涉及腺苷对A(2)Rs的激活或前列腺素的合成。 ATPgammaS对胞质钙没有影响,而BzATP诱导细胞外钙的流入。 ATPgammaS和BzATP抑制IL-2,IL-5,IL-10和IFN-γ的分泌; CD25的表达;固定的抗CD3和可溶性抗CD28 Abs激活CD4(+)T细胞后的增殖和增殖,而不会增加细胞死亡。两者合计,我们的结果表明,胞外腺嘌呤核苷酸通过未知的P2YR介导的cAMP的增加来抑制CD4(+)T细胞的活化,因此可能构成免疫抑制治疗的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号